Explaining the benefits of human genome patent

dc.contributor.authorShahima Akter Topu
dc.date.accessioned2019-12-06T16:25:01Z
dc.date.available2019-12-06T16:25:01Z
dc.date.issued2019-04-12
dc.description.abstractGene patenting has been facing backlash for decades now. Even Michael Crichton, science fiction novelist, as joined the bandwagon speaking against gene patent.1 Such hostility towards patents, the professional interests of academics, researchers and inventors are under the threat of losing their rights over the work they have done. The biotech industry can never be out of discoveries. With constant biological changes, new diseases are appearing and they have to dig deeper. However, not all progress is free. Rewarding the inventors is not at all unfair. This paper will demonstrate that (i) patents are a foundation of the industry. They need to innovate further progress. The reason patent law exists to protect the inventions for a limited period of time. The paper will also demonstrate that (ii) the social myths about gene patent are not really manifested in reality. It will discuss the argument against gene patenting and then will present counter arguments with empirical evidence whether the myths are really true.en_US
dc.identifier.citationShahima Akter Topu. (2019). Explaining the benefits of human genome patent. African Journal of Biological Sciences 1 (2), 46-50.en_US
dc.identifier.issn2663-2187
dc.identifier.urihttp://repository.embuni.ac.ke/handle/embuni/2288
dc.language.isoenen_US
dc.publisherAfrican Journal of Biological Sciencesen_US
dc.subjectPatent system, Concerns, criticisms, Genome patenting, DNA testingen_US
dc.titleExplaining the benefits of human genome patenten_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
3_AFJBS2019016_(p.46-50).pdf
Size:
705.37 KB
Format:
Adobe Portable Document Format
Description:
Short Communication
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: